{"disease":{"id":"uterus-leiomyosarcoma","name":"uterus leiomyosarcoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03926936","title":"FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Frederic Amant","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}